Breaking News Instant updates and real-time market news.

CBPO

China Biologic

$123.18

0.47 (0.38%)

08:32
10/11/16
10/11
08:32
10/11/16
08:32

China Biologic receives CFDA approval for Human Antithrombin III

China Biologic Products announced that Shandong Taibang Biological Products Co. Ltd., the Company's majority-owned subsidiary, recently obtained approval from the China Food and Drug Administration to begin human clinical trials on its Human Antithrombin III product. ATIII is intended to treat hereditary and acquired ATIII deficiency in connection with surgical or obstetrical procedures, and to treat thromboembolism. No manufacturer in China currently offers plasma-derived ATIII product. China Biologic expects to commence clinical trials for the ATIII product in 2017 and complete the trials in two years or longer.

CBPO China Biologic
$123.18

0.47 (0.38%)

02/29/16
JEFF
02/29/16
NO CHANGE
JEFF
China Biologic reported 'strong' results, says Jefferies
Jefferies is upbeat on China Biologic's results, saying that the company's cost controls and cash flow management "continue to be impressive." The firm thinks the company has a number of positive catalysts going forward and keeps a Buy rating on the shares.
03/01/16
FBCO
03/01/16
DOWNGRADE
Target $129
FBCO
Neutral
China Biologic downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Grace Chao downgraded China Biologic Products to Neutral citing valuation and a lack of positive catalysts over the next 12 months following the company's Q4 results. The analyst has a $129 price target for the shares.
06/03/16
JEFF
06/03/16
NO CHANGE
Target $136
JEFF
Buy
Warburg sale of China Biologic shares should remove concern, says Jefferies
Jefferies analyst Kevin Zhao says the sale of 2.775M shares of China Biologic Products by Warburg Pincus should help remove concern about the fund's shareholding reduction and also improve stock liquidity. Warburg's exit should remove an overhang, Zhao tells investors in a research note. He remains positive on China Biologic's organic and inorganic growth and keeps a Buy rating on the shares with a $136 price target. According to Bloomberg data, Warburg's stake in China Biologic will decrease from 15.37% to 4.97% after the sale, Zhao points out.
07/05/16
FBCO
07/05/16
UPGRADE
Target $143
FBCO
Outperform
China Biologic upgraded to Outperform from Neutral at Credit Suisse (pre-open)
Credit Suisse analyst Iris Wang upgraded before the market opened China Biologic Products to Outperform with a $143 price target.

TODAY'S FREE FLY STORIES

ABMD

Abiomed

$108.87

1.48 (1.38%)

11:26
12/05/16
12/05
11:26
12/05/16
11:26
Conference/Events
Abiomed management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

DISCA

Discovery

$26.60

-0.55 (-2.03%)

11:25
12/05/16
12/05
11:25
12/05/16
11:25
Hot Stocks
Breaking Hot Stocks news story on Discovery »

Discovery up nearly 3% as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

SUM

Summit Materials

$23.46

0.2 (0.86%)

11:20
12/05/16
12/05
11:20
12/05/16
11:20
Conference/Events
Summit Materials management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

P

Pandora

$13.59

0.255 (1.91%)

11:20
12/05/16
12/05
11:20
12/05/16
11:20
Options
Bullish option play opened in Pandora »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISCA

Discovery

$26.60

-0.55 (-2.03%)

, T

AT&T

$38.75

0.14 (0.36%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
Discovery CEO says 'well positioned' to take product direct to consumer in 2017 »

Discovery (DISCA) says…

DISCA

Discovery

$26.60

-0.55 (-2.03%)

T

AT&T

$38.75

0.14 (0.36%)

TWX

Time Warner

$93.84

0.04 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 07

    Dec

  • 07

    Dec

SCG

SCANA

$70.63

-0.29 (-0.41%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
SCANA, Westinghouse receive order from DRB about construction milestone payment »

South Carolina Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$30.86

0.06 (0.19%)

11:18
12/05/16
12/05
11:18
12/05/16
11:18
Hot Stocks
BeiGene: BGB-3111 'highly active' in CLL/SLL, well tolerated in Phase 1 study »

BeiGene presented updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

NKE

Nike

$51.77

1.31 (2.60%)

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
Nike moves to monthly highs, levels to watch »

The stock is up over 3%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

TGTX

TG Therapeutics

$5.50

0.05 (0.92%)

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Hot Stocks
TG Therapeutics announces oral data presentation for TGR-1202 at ASH »

TG Therapeutics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

$NYE

NYSE Market Internals

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:16
12/05/16
12/05
11:16
12/05/16
11:16
Technical Analysis
NASDAQ market internals summary »

Volume is very light for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$13.00

0.2 (1.56%)

11:15
12/05/16
12/05
11:15
12/05/16
11:15
Periodicals
New York Times sees more-than-tenfold increase in daily subs, Politico reports »

The New York Times has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

11:15
12/05/16
12/05
11:15
12/05/16
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
12/05/16
12/05
11:15
12/05/16
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

11:14
12/05/16
12/05
11:14
12/05/16
11:14
Recommendations
GW Pharmaceuticals analyst commentary  »

GW Pharmaceuticals price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

ORA

Ormat Technologies

$47.50

0.17 (0.36%)

11:14
12/05/16
12/05
11:14
12/05/16
11:14
Conference/Events
Ormat Technologies management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

FGP

Ferrellgas Partners LP

$6.20

0.55 (9.73%)

11:13
12/05/16
12/05
11:13
12/05/16
11:13
Upgrade
Ferrellgas Partners LP rating change  »

Ferrellgas Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ULTA

Ulta Beauty

$253.39

-4.02 (-1.56%)

11:12
12/05/16
12/05
11:12
12/05/16
11:12
Conference/Events
Ulta Beauty management to meet with Oppenheimer »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 13

    Dec

RSX

Market Vectors Russia ETF

$20.25

0.41 (2.07%)

11:10
12/05/16
12/05
11:10
12/05/16
11:10
Options
Bullish option action in the VanEck Vectors Russia Fund »

Bullish option action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
12/05/16
12/05
11:10
12/05/16
11:10
General news
Treasury announced a $45 B 4-week bill sale for Tuesday »

Treasury announced a $45…

CDK

CDK Global

$56.91

-0.24 (-0.42%)

11:07
12/05/16
12/05
11:07
12/05/16
11:07
Conference/Events
CDK Global management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

11:05
12/05/16
12/05
11:05
12/05/16
11:05
General news
More from Evans: analysts're on cusp of period of rising rates »

More from Evans:…

KEYS

Keysight Technologies

$36.04

0.69 (1.95%)

11:04
12/05/16
12/05
11:04
12/05/16
11:04
Hot Stocks
Keysight, UCSD collaborate to prove 5G viability »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

11:04
12/05/16
12/05
11:04
12/05/16
11:04
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

GDDY

GoDaddy

$34.57

1.28 (3.85%)

11:03
12/05/16
12/05
11:03
12/05/16
11:03
Hot Stocks
GoDaddy expands partnership with SiteLock »

GoDaddy announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.